MEDICATION VIDEO: Aricept® (generic DONEPEZIL) is the world’s most popular drug for Early-stage Alzheimer’s. Does it help in Advanced-stage Alzheimer’s?
CLINICAL INERTIA is when it’s much easier to start someone on a medication, and keep them on, than to take them off. Find out why most advanced dementia patients receive too many expensive, questionable medications.
At long last, we finally have a disease-modifying drug for Alzheimer’s. The FDA recently approved a new drug that promises to slow the progression of the disease. Only five Alzheimer’s treatments have been approved by the FDA up until a decade ago, and this is only the second to address the progression of the disease.
FDA-approved ADLARITY is the once-weekly donepezil patch. See how it compares to donepezil / Aricept / Ebixa tablets for Alzheimer’s.
Swedish researchers find that cholinesterase inhibitors provide cognitive benefits and reduce mortality for up to five years after an Alzheimer’s diagnosis. One medication significantly reduced the risk of developing severe dementia.
Now, a third new Alzheimer’s drug expected to be approved by the Food and Drug Administration (FDA),. The field of new drugs is beginning to show progress in the fight to slow the disease.
First drug to modestly slow Alzheimer’s cognitive decline, based on 1,800 patients.
The FDA Advisory Committee’s endorsement of Leqembi paves way for traditional approval, ushers in a new era for Alzheimer’s
Researchers find that people with dementia who received the drug suvorexant showed a drop in tau and amyloid beta. The drug is already available for sleep problems in Alzheimer’s. Learn more.
NAMENDA® / EBIXA® (generic MEMANTINE) is FDA-approved for Alzheimer’s. Learn about new research on how it may help in preventing or slowing dementia.
The Housing Learning and Improvement Network looks at the design process and philosophy behind creating a successful Extra Care scheme.
Get your message out with Alzheimer’s Weekly! Publish your news prominently on AlzheimersWeekly.com and email it to 30,000 opt-in subscribers. The fee is just $100.
Explore lithium’s impact on Alzheimer’s and dementia prevention. See practical takeaways, including what Dr. Norwitz is doing himself to protect his family’s cognitive health.
SHORT-TERM MEMORY lapses are obvious signs of Alzheimer’s, but other tell-tale signals begin to show much earlier. Learn how to look for semantic impairments, such as simple questions about size.
Three important dementia studies focus on HS-AGING, a type of dementia almost as common as Alzheimer’s in the 85+ group. Yet few people have heard of it. Why? What makes it different?
An intriguing study of 120 grandmothers might surprise you. Doctors know socially engaged people have better cognition and less dementia. But can a person get too much of a good thing? What’s the right balance?
Enjoy this great duet between a musician with dementia and his son. A triumph of spirit over Alzheimer’s! Sing-a-long if you like!
No spam, only news and updates.
